Nortriptyline Hydrochloride Capsule
NDC Package 51672-4002-2
Package Information
Nortriptyline Hydrochloride capsules is nortriptyline hydrochloride is indicated for the relief of symptoms of depression.Endogenous depressions are more likely to be alleviated than are other depressive states. This formulation utilizes a capsule delivery system. Marketed by Taro Pharmaceuticals U.s.a., Inc., this product is identified by NDC 51672-4002 and is authorized under FDA application ANDA075520.
Identification & Billing
- RxCUI: 198045 - nortriptyline HCl 10 MG Oral Capsule
- RxCUI: 198045 - nortriptyline 10 MG Oral Capsule
- RxCUI: 198045 - nortriptyline (as nortriptyline HCl) 10 MG Oral Capsule
- RxCUI: 198046 - nortriptyline HCl 50 MG Oral Capsule
- RxCUI: 198046 - nortriptyline 50 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Taro Pharmaceuticals U.s.a., Inc.
- 51672-4002 - Nortriptyline Hydrochloride
- 51672-4002-2 - 500 CAPSULE in 1 BOTTLE
- 51672-4002 - Nortriptyline Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-4002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-4002-2 identifies a specific commercial package of 500 capsule in 1 bottle of Nortriptyline Hydrochloride, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. This capsule is formulated for oral use and contains nortriptyline hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Taro Pharmaceuticals U.s.a., Inc. on May 08, 2000. The current certification is valid through December 31, 2026.
How is this Taro Pharmaceuticals U.s.a., Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672400202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.